Tlapan, Mexico Clinical Trials

A listing of Tlapan, Mexico clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 11 clinical trials
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

This study aims to evaluate the safety, tolerability and efficacy of molnupiravir (MK-4482) compared to placebo. The primary hypothesis is that molnupiravir is superior to placebo as assessed by the percentage of participants who are hospitalized and/or die through Day 29

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0802)
 (3.5 away) Contact site
  • 14 Jun, 2021
  • +111 other locations
Dapsone for Acute Ischemia Stroke Study

The main purpose of the study is to get information about the safety and efficacy of treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed with anterior territory brain infarct.

ischemic stroke
brain infarction
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
 (2.4 away) Contact site
  • 08 Nov, 2020
  • 1 location
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

Purpose:Retinopathy of prematurity (ROP) continues tobe a major cause of blindness in children. Although ablation of the retina with laser or cryotherapy reduces the incidence of blindness by suppressing the neovascular phase of ROP the visual outcomes after treatment are often poor. Vascular endothelial growth factor(VEGF) has an important role …

antiangiogenic therapy
vascular endothelial growth factor
Asociaci n para Evitar la Ceguera en M xico Hospital "Luis Sanchez Bulnes"
 (6.1 away) Contact site
  • 07 Nov, 2020
  • 1 location
Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy

The purpose of the study is to evaluate the safety and efficacy of 2.5 mg of intravitreal bevacizumab in one eye, versus panretinal photocoagulation in the contralateral eye, for the treatment of patients with untreated symmetric proliferative diabetic retinopathy.

diabetic retinopathy
proliferative diabetic retinopathy
Asociaci n para Evitar la Ceguera en M xico
 (6.1 away) Contact site
  • 07 Nov, 2020
  • 1 location
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

Central serous chorioretinopathy (CSC) has been known since it was first described by Von Graefe and termed “idiopathic detachment of the macula” in 1866, is a well-characterized disorder leading to serous neurosensory elevation of the central macula. The acute form of the disease is associated with focal leakage at the …

retinal pigment
visual impairment
Asociacion para Evitar la Ceguera en Mexico
 (6.1 away) Contact site
  • 07 Nov, 2020
  • 1 location
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

Health Pharma Professional Res /ID# 203597
 (8.2 away) Contact site
  • 13 Jun, 2021
  • +772 other locations
A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)

This is a randomized, double-blind, placebo-controlled, multicenter, 28-day study of adult participants hospitalized with COVID-19, with a safety follow-up telephone call at Day 60.

coronavirus infection
chest x-ray
Hospital General Dr. Manuel Gea Gonz lez
 (3.5 away) Contact site
  • 12 Jun, 2021
  • +32 other locations
Safety Tolerability Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

The primary purpose of this study is to evaluate the safety and tolerability of imipenem/cilastatin/relebactam (IMI/REL) in participants from birth to less than 18 years of age with confirmed or suspected gram-negative bacterial infection. Participants are expected to require hospitalization through completion of intravenous (IV) study intervention, and have at …

Instituto Nacional de Pediatria ( Site 0291)
 (2.6 away) Contact site
  • 14 Jun, 2021
  • +62 other locations
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU001

The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of investigational products in subjects who are known to have an Alzheimer's disease-causing mutation by determining if treatment with the study drug slows the rate of progression of cognitive impairment and improves disease-related biomarkers.

positron emission tomography
mild cognitive impairment
mild dementia
alzheimer's disease
cognitive impairment
Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
 (2.4 away) Contact site
  • 25 Jan, 2021
  • +56 other locations
TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic

The purpose of this study is to assess safety and efficacy of nodal transcranial direct current stimulation in pediatric and teenager population with major depressive disorder in the COVID-19 pandemic.

Instituto Nacional de Neurolog a y Neurocirug a
 (2.4 away) Contact site
  • 14 Jun, 2021
  • 1 location